CAN.AX - Cann Group Limited

ASX - ASX Delayed Price. Currency in AUD

Cann Group Limited

Walter and Eliza Hall Institute of Medical Research
4 Research Avenue La Trobe University
Bundoora, VIC 3083
Australia
61 3 9095 7088
http://www.canngrouplimited.com

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Peter Crock MBAChief Exec. Officer359.29kN/AN/A
Mr. Richard Charles BakerCompany Sec. & CFO204.01kN/AN/A
Mr. Neil GripperGen. Mang. of Operations210.65kN/AN/A
Mr. Steven NotaroHead of Legal204.01kN/AN/A
Mr. Shane DuncanGen. Mang. of Commercial235.45kN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Cann Group Limited engages in research and development, cultivation and production, manufacturing, clinical evaluation, processing, packaging, and distribution/supply of medicinal cannabis for a range of diseases and medical conditions in Australia. The company was founded in 2014 and is based in Bundoora, Australia.

Corporate Governance

Cann Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.